Ontario Fast-Tracks Access to Drugs Targeting 6 Cancers
Ontario’s government says it is fast-tracking public funding for new medications that target six types of cancers through its new trial program. The government said the drugs are being approved under its three-year pilot program, Funding Accelerated for Specific Treatments (FAST). The program aims to “expedit[e] access” for patients to seven to 10 “high priority” […]
Ontario Fast-Tracks Access to Drugs Targeting 6 Cancers Ontario’s government is expediting public funding for new cancer medications through its three-year FAST pilot program. This initiative aims to provide quicker access to seven to 10 high-priority cancer drugs annually. Priority will be given to drugs approved via Project Orbis, an international effort to fast-track regulatory approval for cancer medications.
- Ontario is fast-tracking public funding for new cancer medications.
- The initiative is part of the three-year pilot program called FAST (Funding Accelerated for Specific Treatments).
- The program aims to expedite patient access to seven to 10 high-priority cancer drugs each year.
- Priority will be given to drugs approved through Project Orbis, an international program for fast-tracking cancer medication approval.
No comments yet.
Write a comment